APRIL,TNFSF13 Polyclonal antibody 10680-1-AP proteintech

$149.00
In stock
SKU
10680-1-AP
Catalog No.SizePrice (USD)
10680-1-AP-20UL20 μL$149.00
10680-1-AP-150UL150 μL$449.00
Catalog Number10680-1-AP
SynonymsTNFSF13, TNF- and APOL-related leukocyte expressed ligand 2, TALL-2, TALL2, CD256
HostRabbit
Reactivityhuman
FormLiquid
FormulationPBS, Azide, Glycerol
ApplicationsWB, IHC, ELISA
Host / IsotypeRabbit / IgG
Tested Applications — Positive WB detected inJurkat cells, Raji cells, K-562 cells
Tested Applications — Positive IHC detected inhuman intrahepatic cholangiocarcinoma tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Recommended Dilutions — Western Blot (WB)WB : 1:500-1:1000
Recommended Dilutions — Immunohistochemistry (IHC)IHC : 1:50-1:500
Positive WB detected inJurkat cells, Raji cells, K-562 cells
Positive IHC detected inhuman intrahepatic cholangiocarcinoma tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Western Blot (WB)WB : 1:500-1:1000
Immunohistochemistry (IHC)IHC : 1:50-1:500
Tested Reactivityhuman
Cited Reactivityhuman
ClassPolyclonal
TypeAntibody
ImmunogenCatNo: Ag1056 Product name: Recombinant human APRIL,TNFSF13 protein Source: e coli. -derived, PGEX-4T Tag: GST Domain: 1-247 aa of BC008042 Sequence: MPASSPFLLAPKGPPGNMGGPVREPALSVALWLSWGAALGAVACAMALLTQQTELQSLRREVSRLQGTGGPSQNGEGYPWQSLPEQSSDALEAWESGERSRKRRAVLTQKQKKQHSVLHLVPINATSKDDSDVTEVMWQPALRRGRGLQAQGYGVRIQDAGVYLLYSQVLFQDVTFTMGQVVSREGQGRQETLFRCIRSMPSHPDRAYNSCYSAGVFHLHQGDILSVIIPRARAKLNLSPHGTFLGL Predict reactive species
Full Nametumor necrosis factor (ligand) superfamily, member 13
Calculated Molecular Weight27 kDa
Observed Molecular Weight25-30 kDa
GenBank Accession NumberBC008042
Gene SymbolTNFSF13
Gene ID (NCBI)8741
RRIDAB_2206515
ConjugateUnconjugated
Purification MethodAntigen affinity purification
UNIPROT IDO75888
Storage BufferPBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20 o C storage. 20ul sizes contain 0.1% BSA.
IHC protocol for APRIL,TNFSF13 antibody 10680-1-APDownload protocol
WB protocol for APRIL,TNFSF13 antibody 10680-1-APDownload protocol
humanWB Pathol Oncol Res Reduced APRIL expression induces cellular senescence via a HSPG-dependent pathway. Authors - Ding Weifeng W KD Validated View Article
Citations3
DilutionsWB : 1:500-1:1000 IHC : 1:50-1:500
IsotypeIgG
ClonalityPolyclonal
Clone Number-
ConjugationUnconjugated

TNFSF13 gene encodes tumor necrosis factor ligand superfamily member 13 (or APRIL) belonging to the tumor necrosis factor (TNF) family. APRIL is highly expressed in transformed cell lines, cancers of colon, thyroid, lymphoid tissues and specifically expressed in monocytes and macrophages, and its precursor is cleaved by furin. APRIL may be implicated in the regulation of tumor cell growth and also monocyte/macrophage-mediated immunological processes. Protocols Product Specific Protocols IHC protocol for APRIL,TNFSF13 antibody 10680-1-AP Download protocol WB protocol for APRIL,TNFSF13 antibody 10680-1-AP Download protocol Standard Protocols Click here to view our Standard Protocols

Publications

  1. TNFSF13 Is a Novel Onco-Inflammatory Marker and Correlates With Immune Infiltration in Gliomas.
    Journal: Front Immunol | Authors: Rui Chen | Species: human | Application: IHC
  2. APRIL knockdown suppresses migration and invasion of human colon carcinoma cells.
    Journal: Clin Biochem | Authors: Ding Weifeng W KD Validated | Species: human | Application: WB
  3. Reduced APRIL expression induces cellular senescence via a HSPG-dependent pathway.
    Journal: Pathol Oncol Res | Authors: Ding Weifeng W KD Validated | Species: human | Application: WB

Product Documents

Datasheet

Datasheet

Reviews

Write Your Own Review
You're reviewing:APRIL,TNFSF13 Polyclonal antibody 10680-1-AP proteintech
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.